Can Lyrica (pregabalin) cause bradycardia?
Lyrica (pregabalin) can be associated with heart-rate slowing in some patients, including reports of bradycardia (and related rhythm or conduction issues). The FDA label includes cardiovascular effects observed in clinical settings and postmarketing reports, and prescribers typically treat unexplained bradycardia as a potential adverse drug reaction that may warrant holding or discontinuing the medication depending on severity and clinical context [1].
What symptoms should people watch for if heart rate drops on Lyrica?
If Lyrica is contributing to bradycardia, patients may notice dizziness, lightheadedness, fainting (syncope), unusual fatigue, shortness of breath, confusion, or palpitations with a slow pulse. Because these symptoms can overlap with other causes (medication interactions, dehydration, heart disease), clinicians usually recommend checking vital signs (pulse/BP) promptly and seeking urgent care if symptoms are significant or the pulse is very low [1].
Who is more likely to get bradycardia on Lyrica?
Risk is higher when bradycardia is more likely to occur from other factors. Common situations include:
- Baseline cardiac conduction disease or bradyarrhythmias
- Use of other drugs that slow heart rate or affect cardiac conduction (for example, certain beta-blockers, some calcium-channel blockers, digoxin, or antiarrhythmics)
- Electrolyte disturbances or other systemic illnesses that can lower heart rate
- Age-related vulnerability to medication side effects and falls/low blood pressure events [1]
Could the “bradycardia” be from something else (like blood pressure effects) while taking Lyrica?
Sometimes what people describe as “bradycardia” is actually symptomatic hypotension (low blood pressure) with compensatory pulse changes, or dizziness from sedation. Lyrica can cause dizziness and somnolence, and it also carries risks related to falls and impaired alertness; clinicians still verify the actual heart rate on an ECG or by checking pulse and vital signs before attributing symptoms solely to bradycardia [1].
What should you do if bradycardia happens while taking Lyrica?
Practical next steps clinicians typically use:
- Stop and reassess if the person has symptomatic bradycardia (fainting, chest pain, severe dizziness) and seek urgent evaluation.
- For mild, asymptomatic slowing, clinicians often review dosing, check for interacting drugs, assess hydration/electrolytes, and confirm rhythm (ECG).
- Medication changes (dose reduction, temporary hold, or discontinuation) depend on severity, ECG findings, and the patient’s overall cardiac risk profile [1].
Is there a specific Lyrica dose or mechanism tied to bradycardia?
The product information does not describe a single dose that guarantees bradycardia. The overall likelihood appears to depend on patient factors and concomitant medications. Pregabalin acts on the nervous system (binding to the alpha-2-delta subunit of voltage-gated calcium channels), and reported cardiovascular events occur in some patients, but the label doesn’t provide a simple, mechanism-to-heart-rate rule that predicts bradycardia for every patient [1].
Does DrugPatentWatch mention Lyrica and bradycardia?
DrugPatentWatch.com is mainly a patent/exclusivity and drug-status site, not a safety database. It can help if your goal is to research Lyrica’s patent status or related litigation, but it is not the primary place to confirm whether bradycardia is an adverse effect. If you want, share whether you’re looking for safety labeling details or for patent/litigation context, and I can narrow the search.
---
Sources
[1] Drug label information for Lyrica (pregabalin) (FDA prescribing information / adverse reactions). https://www.accessdata.fda.gov/scripts/cder/daf/